Researchers have succeeded for the first time in reversing a degenerative illness in mice, using a revolutionary gene-editing technique that one day might help cure similar diseases in humans.
Three studies published on Thursday in the journal Science said researchers employed a technique known as clustered regularly-interspaced short palindromic repeats (CRISPR) to cure an adult mouse model suffering Duchenne muscular dystrophy, a disorder that affects one in every 5,000 baby boys.
“This marks the first time that CRISPR has successfully treated a genetic disease inside a fully developed living mammal with a strategy that has the potential to be translated to human therapy,” researchers said.
MUTATIONS
Duchenne muscular dystrophy causes progressive weakness because of genetic mutations that interfere with the production of dystrophin, a protein needed to form healthy muscle.
The novel gene-editing technique fixes mutations that cause genetic diseases by making precise changes to the DNA of the ailing subject, using non-pathogenic viruses as delivery vehicles for the modified genes.
BACTERIAL DEFENSE
Leading scientist on one of the studies and Duke University associate professor Charles Gersbach began focusing on CRISPR/Cas9 — a modified version of a bacterial defense system that targets and slices apart the DNA of familiar invading viruses.
After refining the technique, Gersbach and his team first delivered the therapy directly to a leg muscle in an adult mouse, resulting in an increase in muscle strength as well as some correction of muscles throughout the body, including in the heart.
“There is still a significant amount of work to do to translate this to a human therapy and demonstrate safety,” Gersbach said. “But these results coming from our first experiments are very exciting.”
BUSINESS UPDATE: The iPhone assembler said operations outlook is expected to show quarter-on-quarter and year-on-year growth for the second quarter Hon Hai Precision Industry Co (鴻海精密) yesterday reported strong growth in sales last month, potentially raising expectations for iPhone sales while artificial intelligence (AI)-related business booms. The company, which assembles the majority of Apple Inc’s smartphones, reported a 19.03 percent rise in monthly sales to NT$510.9 billion (US$15.78 billion), from NT$429.22 billion in the same period last year. On a monthly basis, sales rose 14.16 percent, it said. The company in a statement said that last month’s revenue was a record-breaking April performance. Hon Hai, known also as Foxconn Technology Group (富士康科技集團), assembles most iPhones, but the company is diversifying its business to
Apple Inc has been developing a homegrown chip to run artificial intelligence (AI) tools in data centers, although it is unclear if the semiconductor would ever be deployed, the Wall Street Journal reported on Monday. The effort would build on Apple’s previous efforts to make in-house chips, which run in its iPhones, Macs and other devices, according to the Journal, which cited unidentified people familiar with the matter. The server project is code-named ACDC (Apple Chips in Data Center) within the company, aiming to utilize Apple’s expertise in chip design for the company’s server infrastructure, the newspaper said. While this initiative has been
Clambering hand-over-hand, sweat dripping into his eyes, a durian laborer expertly slices a cumbersome fruit from a tree before tossing it down to land with a soft thump in his colleague’s waiting arms about 15m below. Among Thailand’s most famous and lucrative exports, the pungent “king of fruits” is as distinctive in its smell as its spiky green-brown carapace, and has been farmed in the kingdom for hundreds of years. However, a vicious heat wave engulfing Southeast Asia has resulted in smaller yields and spiraling costs, with growers and sellers increasingly panicked as global warming damages the industry. “This year is a crisis,”
HIGH-TECH: As leading-edge process technologies become more complicated, only a handful of players are able to provide design services, the company’s CEO said Artificial intelligence (AI) chip designer Alchip Technologies Ltd (世芯) yesterday said that revenue would grow significantly again in 2026 after adding a major AI chip customer, reversing moderation amid a product transition next year. The Taipei-based application-specific IC (ASIC) designer reiterated its strong revenue growth forecast for this year and 2026 after its stock plummeted about 23 percent to NT$3,145 from a peak of NT$4,085 on March 6 amid growing competition. Alchip said it has built strong partnerships with cloud service providers (CSP), denying that it had lost orders to smaller competitors such as Faraday Technology Corp (智原). Faraday said it has secured